Literature DB >> 19036015

Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome.

N Douet-Guilbert1, J L Laï, A Basinko, N Gueganic, J Andrieux, B Pollet, I Plantier, C Delattre, O Crépin, S Corm, M J Le Bris, F Morel, M De Braekeleer.   

Abstract

Isochromosome of the long arm of chromosome 20 with loss of interstitial material [ider(20q)] is a variant of deletion of chromosome 20q and a rare abnormality in myelodysplastic syndrome (MDS). We studied seven cases with an ider(20q) in MDS. Fluorescence in situ hybridization (FISH) studies showed all proximal breakpoints to be consistently located in 20q11.21 band whereas distal breakpoints were variable. Amplification of HCK, TNFRSF6B and DIDO1 genes included in retained regions associated with loss of tumour suppressor genes in deleted regions could explain cell tumour progression and possibly the less favourable prognosis of ider(20q) compared with del(20q).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19036015     DOI: 10.1111/j.1365-2141.2008.07436.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Dido3 PHD modulates cell differentiation and division.

Authors:  Jovylyn Gatchalian; Agnes Fütterer; Scott B Rothbart; Qiong Tong; Hector Rincon-Arano; Ainhoa Sánchez de Diego; Mark Groudine; Brian D Strahl; Carlos Martínez-A; Karel H M van Wely; Tatiana G Kutateladze
Journal:  Cell Rep       Date:  2013-07-03       Impact factor: 9.423

Review 2.  Using bacterial artificial chromosomes in leukemia research: the experience at the university cytogenetics laboratory in Brest, France.

Authors:  Etienne De Braekeleer; Nathalie Douet-Guilbert; Audrey Basinko; Frédéric Morel; Marie-Josée Le Bris; Claude Férec; Marc De Braekeleer
Journal:  J Biomed Biotechnol       Date:  2011-01-11

3.  Reduced PLCG1 expression is associated with inferior survival for myelodysplastic syndromes.

Authors:  Masayuki Shiseki; Mayuko Ishii; Mari Miyazaki; Satoko Osanai; Yan-Hua Wang; Kentaro Yoshinaga; Naoki Mori; Junji Tanaka
Journal:  Cancer Med       Date:  2019-11-21       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.